Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1579 results found. Search for [ Pharma industry ]

Results 1500 to 1520 of 1579
www.businesstoday.in
August 20, 2008
Avesthagen may have got its IPO timing wrong as BSE Sensex (as on August 14) is down 30.6 per cent from its January 10 peak of 21,210 and most well-known stocks in biotech, pharma and IT are trading at well below their 52-week highs.


Suman Layak
August 20, 2008
Drugs, diagnostics, real estate, private equity and glass may seem a motley bunch of businesses, but it doesn’t matter how diverse your portfolio is if you can emerge top dog. And it’s leadership that Ajay Piramal is aiming for, reports S. Layak.


www.businesstoday.in
August 6, 2008
Of the Fortune 500 companies, just seven are Indian. There isn’t a single Indian company in the top 100. The highest ranked Indian company is a state-owned enterprise, IndianOil Corporation, which comes in at the 116th position.


www.businesstoday.in
August 6, 2008
After Daiichi Sankyo’s purchase of Ranbaxy Labs, Teva Pharma, the world’s largest generics company, acquired Barr Pharma, the US’ fourth largest generics firm. There are two questions on pharma analysts’ lips these days: Who’s next? Are Indian generics players targets for pharma MNCs?


Rachna Monga
August 4, 2008
Not since the technology crash of 2000 have an equity fund manager's investment strategy been tested—and the perils of running a concentrated portfolio exposed.


Shalini S. Dagar
July 24, 2008
Following the strategic sale by the Singh family to Daiichi Sankyo, Ranbaxy Laboratories falls into a regulatory imbroglio with multiple agencies in the US.


www.businesstoday.in
July 10, 2008
The BT-Nielsen ranking of India’s top business schools (BT, July 13) highlights the state of B-school education in the country. Barring the top dozen B-schools or so, and these include the IIMs, there are not enough quality management schools in India.


www.businesstoday.in
July 8, 2008
Risen: By 38.6 per cent, direct tax collections during the first quarter of 2008-09, to Rs 57,373 crore, compared to 28 per cent and Rs 41,391 crore for the corresponding period last year.


K.R. Balasubramanyam
July 7, 2008
Away from the arclights, Wipro’s Consumer Care & Lighting division is expanding its market share and challenging the established players in the business. K.R. Balasubramanyam reports.


www.businesstoday.in
June 26, 2008
The takeover of India’s best-known drug maker, Ranbaxy Laboratories, by Japanese innovator company, Daiichi Sankyo, may have evoked a sense of disbelief all around.


Sanjoy Narayan
July 13, 2008
As India globalises and the world \"shrinks\" even further into a so-called global village, managers will be increasingly called upon to manage cross-cultural teams across geographies. Can the skills required to succeed in such an environment be taught in a classroom? Our cover package, which ranks India's top B-schools, also deals with such, and many other, issues.


Kapil Bajaj
June 25, 2008
Quality MBA education in the country is hurtling towards a quagmire as it is becoming increasingly difficult to find good teachers. Although there's hope yet, the B-schools will need to address the issue in right earnest, says Kapil Bajaj.Slideshows : India's ten best B-Schools IIM-A - An epitome of excellenceISB - One-year wonderFrom BT archives 2007: IIM-A once again retains top perch2006: There are plenty of gainers & losers2005: Emergence of 15 B-school brands2004: To B or not to B?2003: What makes IIM-A dominate?


E Kumar Sharma
June 25, 2008
A healthy dose of pharma stocks in your portfolio can be a good defensive strategy in this volatile market.


E. Kumar Sharma
June 24, 2008
Several Indian drug makers seem ripe for the picking, but buyers will have to come up with compelling offers.


Saumya Bhattacharya & Manu Kaushik
June 23, 2008
Pay packets are looking more rational. But FMCG, telecom and diversified firms are still doling out handsome salaries to trainees, reveals the quarterly BT-Omam Consultants survey.


Rahul Sachitanand
June 23, 2008
Although investment banks, consumer goods giants and consulting companies continue to woo MBA grads with attractive remuneration, many upcoming industries have also staked their claim and are getting a favourable response. A report by BTs R. Sachitanand.Slideshows : India's ten best B-Schools IIM-A - An epitome of excellenceISB - One-year wonderFrom BT archives 2007: IIM-A once again retains top perch2006: There are plenty of gainers & losers2005: Emergence of 15 B-school brands2004: To B or not to B?2003: What makes IIM-A dominate?


T.V. Mahalingam
June 10, 2008
A year ago in late May 2007, Mumbai-headquartered Sun Pharma, together with its subsidiaries, had signed 'definitive agreements' to acquire Taro Pharmaceutical Industries, a multinational manufacturer of generic pharmaceuticals. A year later, the transaction is in tatters and both parties are washing dirty linen in public. Why? T.V. Mahalingam finds out the reasons.


www.businesstoday.in
May 28, 2008
The sheer amount of manufacturing activity taking place in small towns of India is mindboggling. Shops are being set up at breakneck speed and there is massive expansion. Where are these clusters located, and can they really deliver on their promise? Here is what Business Today discovered.


Shalini S. Dagar
May 28, 2008
Quietly, Malvinder and Shivinder have built a clutch of businesses from healthcare to financial services that is already worth more than a fifth of their flagship, Ranbaxy. How big can their non pharma empire get? BT's Shalini S. Dagar finds out. Ranbaxy Laboratories: Clinical precisionGoing for growth: Malvinder Mohan Singh


www.businesstoday.in
May 28, 2008
Companies with revenues between Rs 1,000 crore and Rs 2,000 crore that grew the fastest in 2007.


PAGES 76 OF 79  76777879